About this trial
CT imaging-based skeletal muscle assessment has been found to predict the outcomes of many diseases. Previous evidence revealed that pre-transplant muscle quality and post-transplant muscle loss were associated with transplant outcomes. However, there is no prospective study supporting the aforementioned conclusions. This study aims to prospectively include liver transplant patients from multiple transplant centers, collecting their pre-transplant CT images as well as post-transplant CT images at specific time points. The objective is to further explore and clarify the correlation between skeletal muscle assessment and the prognosis of liver transplant patients. The goal is to provide guidance for peri-transplant health monitoring and disease intervention for liver transplant patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients undergoing deceased donor liver transplantation (DDLT) for the first time
Disqualifiers
Pediatric transplants
Presence of portal vein tumor thrombus according to imageing before transplantation
Presence of macrovascular invasion according to imageing before transplantation
Re-transplants
Trial population
Liver transplant patients from multiple transplant centers in China
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Postoperative mortality
Postoperative recurrence of liver cancer
Specifically for the included patients who undergo liver transplantation for liver cancer
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Zhejiang University
Lead sponsor
First Affiliated Hospital of Zhejiang University
Collaborator
Shulan (Hangzhou) Hospital
Collaborator
The Affiliated Hospital of Qingdao University
Collaborator
West China Hospital
Collaborator
Huashan Hospital
Collaborator
This trial is not recruiting at the moment. You can still explore other options: